Kestra Medical holder plans 15,000-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A notice by Brian Webster covers 15,000 shares of Kestra Medical Technologies, Ltd. common stock for potential sale, with a value of 336,609.41. Merrill Lynch, 225 Liberty St Floor 37, New York, NY 10281, and Nasdaq are listed in connection with this transaction. The shares were acquired on 01/01/2026 via a restricted share issuance granted as part of the issuer’s equity compensation plan.
The disclosure also lists three prior sales of 15,000 common shares each on 04/15/2026, 05/15/2026 and 06/15/2026, with reported values of 300,671.04, 314,329.85 and 312,142.94, respectively.
Key Figures
Key Terms
equity compensation plan financial
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock transaction involving KMTS does Brian Webster’s notice cover?
What type of securities are involved in Brian Webster’s KMTS transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.